Pivotal Advance: Bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease.
about
Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathologyAntibiotic exposure in pregnancy and risk of coeliac disease in offspring: a cohort study.Role of intestinal bacteria in gliadin-induced changes in intestinal mucosa: study in germ-free ratsBifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal modelPathophysiology of celiac diseaseEffects of a gluten-free diet on gut microbiota and immune function in healthy adult humansThe gut microbiome and the brain.Antibiotic exposure and the development of coeliac disease: a nationwide case-control study.Duodenal-mucosal bacteria associated with celiac disease in children.Intestinal microbiota and probiotics in celiac diseaseGut microbes and adverse food reactions: Focus on gluten related disordersNovel players in coeliac disease pathogenesis: role of the gut microbiota.The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop.Isotretinoin Exposure and Risk of Celiac Disease.Intestinal microbiota modulates gluten-induced immunopathology in humanized mice.Antibiotics, gut microbiota, environment in early life and type 1 diabetes.Probiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial.Changes in duodenal tissue-associated microbiota following hookworm infection and consecutive gluten challenges in humans with coeliac disease.Specific Strains of Lactic Acid Bacteria Differentially Modulate the Profile of Adipokines In Vitro.The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.Celiac disease: a model disease for gene-environment interaction.Unraveling the ties between celiac disease and intestinal microbiota.In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options.Celiac disease 2015 update: new therapies.Gut Microbiota and Celiac Disease.An In Vitro Fermentation Study on the Effects of Gluten FriendlyTM Bread on Microbiota and Short Chain Fatty Acids of Fecal Samples from Healthy and Celiac Subjects.Gliadin fragments promote migration of dendritic cells.Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease.Modulation of phenotypic and functional maturation of dendritic cells by intestinal bacteria and gliadin: relevance for celiac disease.Cross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of Autoimmunity
P2860
Q27027791-B13BF455-B5DB-47FA-AC66-1B5FDF9A2776Q33611585-8F1E8A48-5760-44B6-A4F6-7510690F2A0FQ33797774-23172F9C-D6F5-4536-9244-A2C23B1B80F5Q34163254-F36EE601-A1F5-4450-8505-08E56FAA5CB9Q34307239-16E5B929-5F94-44A9-95D2-456A317624A6Q34503583-043D930A-50E1-4FDC-B90D-8B69D1ADDF95Q34652493-90C57311-36F8-4B77-A30C-E41C8298227EQ34802669-BCA6CCA8-0BB4-4285-9331-C8EBEEBC257BQ34802876-C0F50980-2738-4DDD-B1E6-3C65E4ACE655Q35198926-60765E93-7800-4ACC-B209-C57D1D426258Q35498128-B85DA19B-BDEC-4F04-8114-E2220F44833EQ35657347-94B640FF-FE23-431B-9FE8-DE92CF3B9262Q35668237-B5BFF932-F7AF-482B-86F4-B7B1988ABB07Q35750127-E4D628EC-9373-44CB-8031-583C9370E3FDQ35803031-13BCD9E0-DD30-43DB-87D9-01446B353A75Q36277657-2D1D13BB-28D6-4247-8734-02F0CA827689Q37150557-87167070-BE95-4F0C-ADB8-6FDEDC84DC7BQ37402625-061ECE38-6084-45A3-AD7E-A4D78A0F5895Q37694467-B1ABA4BD-989B-493D-B9CF-C4E0C38A88D9Q37729525-E771CF6D-1312-4166-887F-E49231B844E7Q37841101-17601718-5DAD-408E-B7DC-7C36542734D5Q37905044-6A4C36A2-250C-4266-A34D-F5DE4F64E0F7Q37979161-D723465F-C9D2-41C1-8B17-C922664616D4Q38416745-AAECA2C1-026F-4620-AE13-86E6D65340EAQ38685400-AC2AAA1C-8CD3-43BC-9ABA-74BC4F06629FQ41312547-63FD4488-9BB2-448E-92D7-F7D4AC1C25F2Q41951345-10D2F392-02EF-47BC-A13A-EFEFB746DBCEQ53444099-C248AF1E-3E80-4395-AEEC-F344B7645D26Q54296760-3B3DA60A-23E7-43D1-8F15-C946012E3C7CQ59137735-30BEF760-2D08-4C87-949E-261715EF983E
P2860
Pivotal Advance: Bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Pivotal Advance: Bifidobacteri ...... tory milieu of celiac disease.
@en
Pivotal Advance: Bifidobacteri ...... tory milieu of celiac disease.
@nl
type
label
Pivotal Advance: Bifidobacteri ...... tory milieu of celiac disease.
@en
Pivotal Advance: Bifidobacteri ...... tory milieu of celiac disease.
@nl
prefLabel
Pivotal Advance: Bifidobacteri ...... tory milieu of celiac disease.
@en
Pivotal Advance: Bifidobacteri ...... tory milieu of celiac disease.
@nl
P2093
P2860
P356
P1476
Pivotal Advance: Bifidobacteri ...... atory milieu of celiac disease
@en
P2093
P2860
P304
P356
10.1189/JLB.0709471
P577
2009-12-10T00:00:00Z